LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Myriad Genetics Inc. (MYGN) Has Raised Its FY13 Revenue Estimate To $595 - $600 Mln From $575 - $585 Mln 5/7/2013 4:22:46 PM
  • Myriad Genetics Inc. (MYGN) Has Raised Its FY13 EPS Estimate To 1.65 - 1.67 From 1.55 - 1.58 5/7/2013 4:22:18 PM
  • Myriad Genetics Inc. (MYGN) Has Raised Its FY13 EPS Estimate To 1.55 - 1.58 From 1.50 - 1.55 2/5/2013 4:29:17 PM
  • Myriad Genetics Inc. (MYGN) Has Raised Its FY13 Revenue Estimate To $575 - $585 Mln From $570 - $585 Mln 2/5/2013 4:28:32 PM
  • Myriad Genetics Inc. (MYGN) Announces $200 Mln Stock Repurchase Plan 2/5/2013 4:27:10 PM
  • RBC Capital Markets Reiterates Myriad Genetics Inc. (MYGN) At Outperform With $32 Up From $30 Price Target 11/6/2012 10:59:33 AM
  • RBC Capital Markets Is Raising Myriad Genetics Inc. (MYGN) Q4 13 Estimate To 0.40 From 0.38 11/6/2012 10:46:38 AM
  • RBC Capital Markets Is Cutting Myriad Genetics Inc. (MYGN) Q3 13 Estimate To 0.38 From 0.39 11/6/2012 10:46:33 AM
  • RBC Capital Markets Is Raising Myriad Genetics Inc. (MYGN) Q2 13 Estimate To 0.39 From 0.37 11/6/2012 10:46:29 AM
  • RBC Capital Markets Is Raising Myriad Genetics Inc. (MYGN) 2013 Estimate To 1.53 From 1.46 11/6/2012 10:46:02 AM
  • RBC Capital Markets Is Increasing Myriad Genetics Inc. (MYGN) Q4 13 Rev. Estimate To 152.2 M From 146.2 M 11/6/2012 10:45:49 AM
  • RBC Capital Markets Is Increasing Myriad Genetics Inc. (MYGN) Q3 13 Rev. Estimate To 146.9 M From 143.5 M 11/6/2012 10:45:42 AM
  • RBC Capital Markets Is Increasing Myriad Genetics Inc. (MYGN) Q2 13 Rev. Estimate To 143.9 M From 139.6 M 11/6/2012 10:45:33 AM
  • RBC Capital Markets Is Increasing Myriad Genetics Inc. (MYGN) 2013 Rev. Estimate To 576.4 M From 560.7 M 11/6/2012 10:45:21 AM
  • Myriad Genetics Inc. (MYGN) Has Raised Its FY13 Revenue Estimate To $570 - $585 Mln From $550 - $565 Mln 11/5/2012 4:16:16 PM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap